NCT06377150Completed
ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study
Source: ClinicalTrials.gov · Last updated 29 Jun 2025
Brief summary (registry, in English)
Retrospective chart review study to elucidate the phenotype and genotype of children with ABCA4-associated Stargardt disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 39 (actual)
- First submitted
- 12 Apr 2024
- Start date
- Apr 2022
- Primary completion date
- Mar 2024
- Lead sponsor
- University Hospital Tuebingen
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT06377150
What you commit to
- Study type: Observational
- Participants enrolled: 39
- From Apr 2022 to the primary completion date, Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- 18 years old and older
Who the study is looking for
- genetically confirmed ABCA4-associated inherited retinal dystrophy
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Tuebingen Coordinator of this site? Confirm its status | Tübingen | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.